Datavant launches $652 million term loan at SOFR plus 425-450 bps

By Sara Rosenberg

New York, March 20 – Datavant (Ciox Health/CT Technologies Intermediate Holdings Inc.) launched on Wednesday its roughly $652 million first-lien term loan due December 2028 with price talk of SOFR plus 425 basis points to 450 bps with an original issue discount of 99 to 99.5, according to a market source.

The term loan has 101 soft call protection for six months.

The company’s roughly $752 million of credit facilities (B) also include a $100 million upsized revolver due December 2028.

UBS Investment Bank, Goldman Sachs Bank USA and Deutsche Bank Securities Inc. are the arrangers on the deal.

Commitments are due at noon ET on March 27.

Proceeds will be used to extend the company’s existing revolver and term loan by three years.

Datavant, backed by New Mountain Capital, is an Alpharetta, Ga.-based health care data logistics company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.